CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer
CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer have?
CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer has 120 citations in the OpenAlex counts ScholarIQ stores.
When was CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer published?
CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer has 2024 year in the ScholarIQ index.
What is the open-access status of CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer?
CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer has gold oa status in the ScholarIQ index.
What is the DOI of CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer?
The DOI for CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer is on the source record.
What is the PMID of CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer?
The PMID for CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer is on the source record.
What is the OpenAlex record for CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer?
The OpenAlex for CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer is on the source record.